Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maaz Asher Khurram"'
Publikováno v:
The Lancet. Oncology. 17(9)
According to a recent Review in The Lancet Oncology, only two antibody–drug conjugates have been approved by the US Food and Drug Administration (FDA)—brentuximab vedotin and ado-trastuzumab emtansine. Brentuximab vedotin was approved in 2011 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae12c7c7d04db04991b1aa5432b8270e
https://pubmed.ncbi.nlm.nih.gov/27599139
https://pubmed.ncbi.nlm.nih.gov/27599139
Autor:
Satsuki Fukushima, Maaz Asher Khurram, Tsuyoshi Ishikawa, Shigeo Masuda, Atsuhiro Saito, Shigeru Miyagawa, Terumi Nakamura, Yoshiki Sawa
Publikováno v:
Nature Reviews Cardiology. 13:574-574
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab62d1c052cd289ff9f9b0995075e11
https://doi.org/10.1038/nrcardio.2016.129
https://doi.org/10.1038/nrcardio.2016.129